The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus
- PMID: 14977483
- DOI: 10.1089/15258160360732768
The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus
Abstract
The mechanism by which the developing fetus survives the maternal immunity has eluded investigators and remains a central paradox in the field of stem cell research. If the mechanism can be defined, allogenic stem cells may find increased utility after transplantation. While several theories have been advanced, the differential expression of HLA antigens on trophoblasts has been the focus of many studies. Interestingly, an inverse relationship between HLA-G (nonclassical class I molecules) and class I MHC gene expression exists early in pregnancy. HLA-G transcripts are present in quite significant amounts in first-trimester placental tissue, particularly in the extravillous membranes, while the opposite occurs at term. This kind of expression is consistent with the theory that HLA-G might play a role in fetal protection. This could be consequent to either nonimmune (structural) or immune functions at the maternal-fetal interface. Current evidence suggest an immune function wherein HLA-G protects fetal cells from maternal uterine natural killer (NK) cells, which are found in large numbers within cells invading the trophoblasts. This effect has been attributed to maternal NK receptor alterations as well as inhibition of maternal NK cell traffic across the placenta. The recent identification of HLA-G polymorphism brings into play the potential role of these isoforms in fetal protection. Polymorphism may be associated with differential function or may effect linkage disequilibria with other HLA variants, providing fetal protection.
Comment in
-
Could the functional expression of HLA-G be exploited for successful stem cell transplantation and engraftment?J Hematother Stem Cell Res. 2003 Dec;12(6):757-8. doi: 10.1089/15258160360732777. J Hematother Stem Cell Res. 2003. PMID: 14977484 No abstract available.
Similar articles
-
HLA Class I protein expression in the human placenta.Early Pregnancy (Cherry Hill). 2001 Jan;5(1):67-9. Early Pregnancy (Cherry Hill). 2001. PMID: 11753519
-
Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.Am J Reprod Immunol. 1998 Sep;40(3):136-44. doi: 10.1111/j.1600-0897.1998.tb00405.x. Am J Reprod Immunol. 1998. PMID: 9764357
-
HLA-G inhibits the transendothelial migration of human NK cells.Eur J Immunol. 2000 Feb;30(2):586-93. doi: 10.1002/1521-4141(200002)30:2<586::AID-IMMU586>3.0.CO;2-Y. Eur J Immunol. 2000. PMID: 10671215
-
HLA-G and immune tolerance in pregnancy.FASEB J. 2005 May;19(7):681-93. doi: 10.1096/fj.04-2078rev. FASEB J. 2005. PMID: 15857883 Review.
-
Immunological relationship between the mother and the fetus.Int Rev Immunol. 2002 Nov-Dec;21(6):471-95. doi: 10.1080/08830180215017. Int Rev Immunol. 2002. PMID: 12650238 Review.
Cited by
-
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.Biochem Pharmacol. 2015 Jun 15;95(4):211-26. doi: 10.1016/j.bcp.2015.04.012. Epub 2015 Apr 24. Biochem Pharmacol. 2015. PMID: 25916268 Free PMC article. Review.
-
HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.Immunogenetics. 2006 May;58(4):241-51. doi: 10.1007/s00251-005-0076-z. Epub 2006 Mar 29. Immunogenetics. 2006. PMID: 16570139
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials